INTRODUCTION 1
Methicillin-resistant Staphylococcus aureus (MRSA) has become a major cause of 2 infection among patients in hospitals and in the community worldwide. The success of MRSA is 3 partly due to its ability to adapt rapidly and to survive mainly through the acquisition and 4 expression of exogenous genes encoded by plasmids, bacteriophages and other mobile genetic 5 elements from other S. aureus strains and from coagulase-negative staphylococci (CoNS) (2, 9, 6 11, 20) . 7 ST8-MRSA-IVa (also known as USA300) is the predominant community-acquired (CA)-8 MRSA strain in the USA where its incidence is also increasing in healthcare settings but this 9 clone has also been recovered in many other countries worldwide (28). The extensive spread and 10 success of ST8-MRSA-IVa has been partially attributed to the presence of a mobile genetic 11 element termed the arginine catabolic mobile element (ACME) which is thought to play an 12 important role in its growth and survival (3). While most ST8-MRSA-IVa isolates identified to 13 date contain ACME (8, 15, 28) , it has only been identified in a small number of other MRSA 14 genotypes including ST5-MRSA-II (4, 8), ST59-MRSA-IVa (4), ST97-MRSA-V (5), ST1-15 MRSA-IVa (5), ST5-MRSA-IV (6) and ST239-MRSA-III (7) and among just two ST8-16 methicillin-susceptible S. aureus isolates (8). ACME has also been identified among CoNS 17 including S. epidermidis, S. haemolyticus and S. capitis where it appears to be more prevalent and 18 to have a more diverse genetic organization than in S. aureus (1, 3, 13, 21) . 19
The ACME elements described in detail to date range in size from 31 kb in ST8-MRSA-20
IVa to 34 kb in S. epidermidis (3). They are integrated downstream of the staphylococcal 21 chromosomal cassette (SCC) harboring the methicillin resistance gene mecA (SCCmec) and use 22 the same attachment site for integration within orfX as SCCmec. Similar to SCCmec elements, 23
Whole genome sequencing and PCR to close gaps between contigs. The whole 1 genome of one MRSA isolate representative of the predominant spa, dru and SCCmec type 2 combination of ST22-MRSA-IV isolates identified as harboring ACME-arc genes (M08/0126) 3 was sequenced to determine the location and genetic organization of ACME. High-throughput de 4 novo sequencing was undertaken commercially by Geneservice (Source BioScience plc, 5
Nottingham, UK) using the Illumina Genome Analyzer System (Illumina, Essex, UK). Contigs 6 were analyzed using the Artemis DNA sequence viewer and annotation tool (23) and BLAST 7 software (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Contigs that were identified as containing 8 ACME or SCCmec-associated DNA sequences were aligned using the BioNumerics (version 5.1) 9
(Applied Maths, Ghent, Belgium) and DNA Strider (version 1.3f11) (CEA Saclay, Gif-sur-10
Yvette, France) software packages. Any gaps identified between ACME and SCCmec-related 11 contigs in the whole genome sequence of M08/0126 were closed by primer walking using PCR 12 with primers based on the surrounding contigs and the Expand long-template PCR system (Roche 13 Diagnostics Ltd, West Sussex, UK) followed by amplimer sequencing. Data were analysed and 14 overlapping sequences were assembled using the BLAST, Bionumerics and DNA Strider 15 software packages. 16
Confirmation of the genetic organization and location of ACME and SCCmec. 17
Having determined the genetic organization of ACME and SCCmec in the ST22-MRSA-IVh 18 isolate M08/0126 using the whole genome sequence, the inferred genetic organization was 19 confirmed by designing three overlapping primer pairs based on this sequence to amplify the 20 ACME and SCCmec region of M08/0126 extending from (i) orfX to ACME-arcA (Table 2 , 21 primers orfX F1 and arcA R1), (ii) ACME-arcA to the region with homology to the J1 region of 22 SCCmec I (Table 2 , primers arcA F1 and ΔCE010 R1) and (iii) the SCCmec I J1 region to 23 Diagnostics Ltd.). PCR products were visualized by agarose gel electrophoresis and the sizes of 1 amplicons obtained were compared to the expected size of amplicons based on the whole genome 2 sequence (Table 2) . 3
Confirmation of the genetic organization of ACME and SCCmec in all ACME-arc-4 positive ST22-MRSA-IVh isolates was performed using primer pairs designed to amplify the 5 junction regions between orfX and ACME (Table 2, primers orfX F1 and ACMEII R1) and the 6 region with homology to J1 of SCCmec I and SCCmec IVh (Table 2 , ACME/SCCmec I F1 and 7 J3IVh R1). PCR assays were performed using GoTaq DNA polymerase (Promega). PCR 8 products were visualized by agarose gel electrophoresis and the sizes of amplicons were 9 compared to those obtained with template DNA from the whole genome sequenced isolate 10 M08/0126 and to the expected size of amplicons based on the whole genome sequence of this 11 isolate (Table 2) . Since all isolates yielded amplicons of the same size using these PCR assays, 12 the PCR products for the whole genome sequenced isolate (M08/0126) and one other isolate 13 (M08/0119) were sequenced commercially by Geneservice (Source BioScience plc, Dublin, 14 Ireland) to confirm the DNA sequence of these junction regions. 15
Confirmation of the location of ACME in all ACME-arc-positive ST8-MRSA-IVa 16 isolates was performed using PCR with primers C and IVa R1 (Table 2) to amplify from the J1 17 region of SCCmec IVa to ACME I based on the previously published whole-genome sequence of 18 the ST8-MRSA-IVa isolate FPR3757 (Genbank accession number NC007793). Template DNA 19 from one ACME-arc-positive ST22-MRSA-IVa isolate (E1401) which failed to yield any 20 amplicons using the primers based on the ACME/SCCmec region of the whole genome 21 sequenced ST22-MRSA-IVh isolate M08/0126 was also investigated using the ST8-MRSA-22
IVa/USA300-specific primers. PCR assays were performed as described above and the sizes of 23 amplicons were compared to the expected size of amplicons based on the whole genomeST8-MRSA-IVa isolate (ML224) and the ST22-MRSA-IVa isolate (E1401) were sequenced by 1 Geneservice (Source BioScience plc, Dublin, Ireland) to confirm the DNA sequence of this 2 junction region in these isolates. 3
Nucleotide sequence accession numbers. The nucleotide sequence of the 4 ACME/SCCmec composite island (SCCmec-CI) of ST22-MRSA-IVh has been deposited in 5
GenBank under accession number FR753166. 6 7 RESULTS 1 Identification of ACME-arc-positive MRSA isolates. Twenty-three of the 238 isolates 2 investigated (9.7%) were found to be positive for ACME-arc genes (Table 3) . Using MLST, 3
SCCmec typing and the DNA microarray, the ACME-arc-positive isolates were assigned to two 4 distinct genotypes, ST8-MRSA-IVa (7/23, 30%) and ST22-MRSA-IV (16/23, 70%) ( Table 3) . 5
The DNA microarray results for the ACME-arc-positive isolates are shown in Table 4 . 6 ACME-arc-positive ST8-MRSA-IVa isolates. The seven ACME-arc-positive ST8 7
isolates were pvl-positive, harbored SCCmec IVa, exhibited four pulsed-field types (PFTs), 8 belonged to spa type t008 (6/7 isolates) or t4306 (1/7 isolates) and to dru type dt9g (6/7 isolates) 9 or dt9z (1/7 isolates). Each of these spa or dru type pairs differ in single repeats only (Table 4) . 10
The DNA microarray assigned these isolates to the ST8-MRSA-IV clone and, in addition 11 to detecting mecA and the ACME-arc genes, showed they all harbored the beta-lactam resistance 12 gene blaZ, the erythromycin resistance genes msr(A) and mph(C), the fosfomycin resistance gene 13 fosB, enterotoxins K and Q (sek and seq, respectively), the pvl genes lukF-PV and lukS-PV and 14 the immune evasion cluster (IEC) genes sak, chp and scn (Table 4 ). The DNA microarray 15 differentiated these seven isolates into three microarray groups designated ST8-MRSA-IV (a)-(c) 16 (Table 4) . Microarray group ST8-MRSA-IV (a) contained five isolates harboring the 17 aminoglycoside and streptothricin genes aphA3 and sat, respectively. The single isolate in 18 microarray group ST8-MRSA-IV (b) also harbored aphA3 and sat, but in addition, carried the 19 multidrug resistance gene cfr and the chloramphenicol resistance gene fexA. This is the first ST8-20 MRSA-IVa (USA300) isolate reported to carry cfr; detailed localization of cfr and fexA to a novel 21 conjugative plasmid (pCSFS7) in this isolate has been described in a recent study (25) . The single 22 isolate in microarray group ST8-MRSA-IV (c) lacked aphA3, sat, cfr and fexA (Table 4) . 23 spa type t3185 and dru type dt10o (Table 3) . One ST22-MRSA-IV isolate was pvl-positive, 1 harbored SCCmec IVa (22) and exhibited a different PFT (01003), spa (t2480) and dru (dt10am) 2 type to the other ACME-arc-positive ST22-MRSA-IV isolates (Table 3) . 3
The DNA microarray assigned these 16 ACME-arc-positive isolates to the ST22-MRSA-4 IV clone and, in addition to detecting mecA and the ACME-arc genes, showed they all carried the 5 macrolide, lincosamide and streptogramin B resistance gene erm(C) and the enterotoxin gene 6 cluster (egc) consisting of seg, sei, sem, sen, seo and seu/y ( Table 4 ). Fifteen of the sixteen ST22-7 MRSA-IV isolates harbored the beta-lactam resistance gene blaZ. These isolates were 8 differentiated into four microarray groups designated ST22-MRSA-IV (a)-(d) ( Table 4) . isolates. In addition, microarray group ST22-MRSA-IV (c) isolates lacked the blaZ gene ( Table  18 4). 19
Confirmation of ACME-arcA in isolates identified as ACME-arc-positive by DNA 20 microarray. The presence of ACME in the 23 ACME-arc-positive isolates was confirmed by 21 PCR using previously described primers specific for the ACME-arcA region. All isolates yielded 22 amplicons of the expected size corresponding to the amplification of an internal segment of 23 Novel ACME and SCCmec composite island in ST22-MRSA-IVh isolate M08/0126. 1 Whole genome sequencing of the ST22-MRSA-IVh isolate M08/0126 yielded 272 contigs 2 ranging in size from ca. 200 bp to 200 kb. ACME and/or SCCmec-associated DNA sequences 3 were identified in five contigs ranging in size from 1.4 kb to 73 kb. The gaps between ACME and 4 SCCmec-related contigs were closed using long-range PCR amplification and sequencing with 5 primers based on the surrounding contigs. This analysis revealed the presence of a novel ca. 46-6 kb ACME and SCCmec composite island (ACME/SCCmec-CI) in M08/0126 consisting of a 12-7 kb DNA region previously identified in ACME type II in S. epidermidis ATCC 12228, a 8 truncated copy of the J1 region of SCCmec I and a complete SCCmec IVh element ( Fig. (1a) ). 9
Because the present study focused on the novel 46-kb ACME/SCCmec-CI element, DNA regions 10 outside of the SCCmec and/or ACME sequences of any of these or the other contigs are not 11 discussed further here. 12
In all MRSA and methicillin-resistant S. epidermidis (MRSE) isolates reported to harbor 13 SCCmec and ACME, SCCmec has always been found to be located within orfX with ACME 14 downstream of SCCmec ( Fig. 1(b) and (c)). While the ACME/SCCmec-CI was integrated at the 15 same nucleotide position within orfX in M08/0126 as in all other MRSA/MRSE isolates 16 described to date, the ACME element was located within orfX and the SCCmec element was 17 located downstream of ACME ( Fig. 1(a) ). 18
The ACME-CI was flanked by 18-bp direct repeat (DR) sequences, one abutting the 19 orfX/ACME junction within the ACME-CI (DR-1, Fig. 1(a) ) and the other in the chromosomal 20 region immediately adjacent to the right terminus of SCCmec IVh (DR-2, Fig. 1(a) ). Identical 7-21 bp inverted repeat (IR) sequences were also identified within DR-1 (IR-1, Fig. 1(a) ) and 22 immediately preceding DR-2 (IR-2, Fig. 1(a) ). Two additional 18-bp DRs and three additional 7-23 bp IRs were also identified within the ACME-CI. The two additional DRs were identified in the1(a), DR-3; 13/18 nucleotides identical to DRs-1 and -2) and within SCCmec IVh adjacent to the 1 J1 SCCmec I/SCCmec IVh junction ( Fig. 1(a) . The three additional IRs were identified within 2 DR-3 ( Fig. 1) and DR-4 ( Fig. 1(a) and at the J1 SCCmec I/SCCmec IVh junction region within J1 3 SCCmec I (Fig. 1(a) . The ACME region in M08/0126 consisted of a ca. 12-kb DNA sequence 4 and included the ACME-arc genes in the same order and orientation as previously described for 5 ACME ( Fig.1(a) ). The ACME-arc genes (including argR) exhibited >99.8% DNA sequence 6 identity with those of the ST8-MRSA-IVa (USA300) isolate FPR3757 and S. epidermidis ATCC 7 12228 ( Fig. 1(b) and (c) ). The ACME-arc genes were surrounded by a ca. 5.8-kb DNA sequence 8 (2.7 kb downstream and 3.1 kb upstream) with 99% DNA sequence identity with the region 9 surrounding ACME-arc in S. epidermidis ATCC 12228 (Fig. 1) . A complete IS431 element was 10 identified immediately adjacent to the ACME region ( Fig. 1(a) ). A ca. 9.5-kb region consisting of 11 several open reading frames (ORFs) in the same order and orientation as previously only found in 12 the J1 region of SCCmec I (Genbank accession number AB033763) was identified ca. 1.5 kb 13 upstream of IS431 in the ACME-CI ( Fig. 1(a) ). This region included all ORFs previously 14 identified within the J1 region of SCCmec I extending from the SCCmec I/chromosomal junction 15 to within ORF CE010. ORF CE010 contains a Shine-Dalgarno repeat and is similar to the gene 16 encoding the S. aureus plasmin sensitive surface protein (pls). All ORFs within this region of 17 ACME-CI, except for the one ORF with homology with CE010, exhibited 99-100% DNA 18 sequence identity with the corresponding ORFs from SCCmec I. The CE010 region in SCCmec I 19 consists of a 5097-bp DNA sequence while in ACME-CI it was 3451 bp and exhibited 50% DNA 20 sequence identity with CE010; no other significant homology was found with any sequence in the 21 Genbank database. A complete SCCmec IVh element with a class A mec complex and type 2 ccr 22 genes was identified adjacent to this SCCmec I region in ACME-CI (Fig. 1) . 23 was confirmed by PCR using primers designed to amplify the orfX/ACME and the J1 SCCmec 1 I/SCCmec IVh junction regions in ACME-CI (Table 2 ). All isolates yielded amplicons of the 2 expected size using both primer pairs. Sequencing of the amplicons from M08/0126 and one 3 other isolate (M08/1119) confirmed that these junction regions were identical to the 4 corresponding region determined by whole genome sequencing of M08/0126. PCR amplification 5 using these two primers pairs was also attempted on template DNA from the ACME-arc-positive 6 ST22-MRSA-IVa isolate E1401 (Table 2 ) but no amplicons were obtained. 7
Determination of the location of ACME in ST8-MRSA-IVa and ST22-MRSA-IVa 8 isolates. Investigation of the location of ACME in the seven ACME-arc-positive ST8-MRSA-9
IVa isolates was performed using PCR and primers to amplify from the J1 region of SCCmec IVa 10 to within ACME type I based on the previously published whole genome sequence of the 11 ACME-positive ST8-MRSA-IVa (USA300) isolate FPR3757. In addition, PCR using this 12 SCCmec IVa/ACME primer pair was also performed on ST22-MRSA-IVa isolate E1401 because 13 this isolate failed to yield any amplicons using ACME-CI specific primers and, unlike the other 14 ACME-positive ST22-MRSA-IV isolates, E1401 harbored SCCmec IVa which is the same 15 SCCmec type identified in the ACME-positive ST8 isolates recognized in the present study. All 16 isolates yielded amplicons of the expected size indicating the presence of ACME adjacent to 17 SCCmec in these isolates, similar to the location described previously for ST8-MRSA-IVa 18 (USA300). Sequencing of the amplicons from one ST8-MRSA-IVa isolate (ML224) and the 19 ST22-MRSA-IVa isolate (E1401) revealed that the SCCmec IVa/ACME junction regions in these 20 two isolates exhibited 100% DNA sequence identity with each other and with that of the ST8-21 MRSA-IVa (USA300) isolate FPR3757. 22
Although ACME is widespread among ST8-MRSA-IVa (USA300) isolates, it has only 2 been identified in a small number of isolates belonging to other MRSA clones. This report is, to 3 the best of our knowledge, the first description of ACME with significant DNA sequence identity 4 with ACME type II from S. epidermidis in the pandemic ST22-MRSA-IV clone. The emergence 5 of an ACME-positive variant of ST22-MRSA-IV may have the potential to enhance the growth 6 and survival of this already successful MRSA clone. This is especially worrying because like 7 ST8-MRSA-IVa (USA300), one of the ACME-positive ST22-MRSA-IV isolates was also pvl-8 positive. While ACME does not directly act as a virulence factor or contribute directly to the 9 ability of staphylococci to cause disease, evidence suggests that it contributes to bacterial growth, 10 survival, transmission and colonization within the host (3, 4, 13, 19) . 11
In the present study, ACME was identified in two distinct strains of ST22-MRSA-IV; one resistance, and an IEC-encoding lysogenic bacteriophage. The combination of ACME and high-21 level mupirocin resistance in ST22-MRSA-IV is an important finding because while ACME may 22 enhance host-tissue colonization, high-level mupirocin resistance may also play a role in 23 successful host colonization by resisting nasal decolonization by mupirocin therapy, a majorThe ACME-positive ST22-MRSA-IVh isolates harbored a 46-kb ACME/SCCmec-1 composite island (CI) with several novel characteristics. Firstly, this ACME/SCCmec-CI 2 consisted of a 12-kb ACME region with >99% DNA sequence identity with part of ACME II 3 previously only described in S. epidermidis, a 9.5-kb DNA region with significant homology to 4 part of the J1 region of SCCmec I and a SCCmec IVh element. The presence of a DNA sequence 5 with significant identity to the J1 region of SCCmec I was a surprising finding since SCCmec 6 types I and Ia have not been identified among Irish MRSA isolates since 1999. MRSA strains 7 that predominated in Irish hospitals in the 1970s and 1980s harbored SCCmec I and strains 8 harboring SCCmec Ia were recovered sporadically between 1989 and 1999 (24) . It is interesting 9 to speculate that both ACME and the SCCmec I J1 region of the ST22-MRSA-IVh 10 ACME/SCCmec-CI may have originated in CoNS and that recombination and horizontal transfer 11 of DNA occurred between CoNS and a ST22-MRSA-IVh isolate resulting in this novel ACME-12 SCCmec-CI. While the precise order of these events and the direction of transfer are unknown, 13 the higher prevalence and diversity of ACME and SCCmec among CoNS and the fact that the 14 ACME II allotype has not previously been identified in MRSA suggests that it may have 15 originated in CoNS with subsequent transfer to S. aureus (13). However, confirmation of this 16 hypothesis requires detailed molecular characterization of ACME and SCCmec in CoNS. Other 17 studies have also found evidence to suggest interspecies transfer of DNA, including ACME, 18
SCCmec, SCC-CI and antimicrobial resistance genes between S. aureus and CoNS (13, 18, 25, 19 27) . 20 A unique and striking feature of the novel ACME/SCCmec-CI reported in the present 21 study is the location of ACME and SCCmec relative to orfX. In contrast to previously described 22 ACME/SCC-CIs in which ACME is located downstream of SCCmec (3), SCCmec was located 23 downstream of ACME in the ST22-MRSA-IVh isolates. This suggests that ACME may haveanalysis of ST22-MSSA isolates for the presence of ACME may help to further clarify this. The 1 IS431 element identified adjacent to the ACME region of ST22-MRSA-IVh may have played a 2 role in the emergence of this novel ACME/SCCmec element, as insertion sequence elements have 3 been shown previously to promote genetic rearrangements (10). 4
In the ACME-positive pvl-positive ST22-MRSA-IVa isolate reported in the present study, 5 ACME was located downstream of SCCmec IVa as previously described in ST8-MRSA-IVa 6 (USA300) isolates (3). The same ACME and SCCmec IVa genetic organization was also found 7 among ACME-positive pvl-positive ST8-MRSA-IVa isolates recovered in Ireland between 2003 8 and 2005, suggesting that such isolates may be a more likely source of ACME in the pvl-positive 9 ST22-MRSA-IVa isolate rather than the ST22-MRSA-IVh isolates with the novel ACME-10 SCCmec-CI first recognised in 2008. However, CoNS may also have been the source of the 11 ACME element in the earlier isolate. More detailed studies of ACME and SCCmec in S. aureus 12 and CoNS are required to clarify this. 13
In conclusion, the finding of ACME in two distinct strains of ST22-MRSA-IV and the 14 significant differences identified in the genetic organization of ACME in both strains suggests 15 that ACME has been acquired by ST22-MRSA-IV on at least two independent occasions and that 16 this acquisition may have involved interspecies transfer of ACME between CoNS and S. aureus. 17 This finding also suggests that ACME has the potential to spread widely not only among ST8-18 MRSA-IV and ST22-MRSA-IV isolates but also among other MRSA clones. To date, the 19 horizontal transfer of ACME appears to be a relatively rare event, because although it is 20 widespread among ST8-MRSA-IVa it has only been identified among a small number of isolates 21 belonging to other MRSA clones (4, 5, 6, 7, 8) , and only 10% of MRSA isolates in the present 22 study were found to harbor ACME. While the reasons for this are still unclear, it may be that 23 acquisition of a large mobile genetic element such as ACME, which previously have beenin the ST22-MRSA-IVh isolates in the present study was the smallest ACME described to date 1 (ca. 14 kb from DR-1 to DR-3) and therefore, may be a more competitive mobile genetic element 2 and may not adversely affect bacterial fitness. The presence of ACME may provide a selective 3 advantage to ST22-MRSA-IV isolates and may therefore enhance further dissemination of this 4 already successful MRSA clone. Confirmation of this suggestion requires ongoing surveillance of 5 ST22-MRSA-IV and other MRSA strains to determine if ACME-positive ST22-MRSA-IV 6 isolates become widespread and if this ACME element successfully spreads among other MRSA 7 strains. This study provides further evidence of the ongoing and rapid evolution of MRSA and of 8 the importance of CoNS as a potential reservoir of virulence-associated and antimicrobial 9 resistance genes in S. aureus. 
Figure legend
FIG. 1. Schematic diagram showing the genetic organization of (a) the novel ACME/SCCmec composite island (CI) identified in the present study in ST22-MRSA-IVh isolate M08/0126 (Genbank accession number FR753166), (b) the ACME-CI previously reported in S. epidermidis ATCC 12228 (NC004461) and (c) the ACME and SCCmec elements previously identified in the ST8-MRSA-IVa (USA300) isolate FPR3757 (FPR3757). The structure of the novel ACME-CI was determined by high-throughput wholegenome sequencing of M08/0126 and was confirmed using primers spanning the ACME/SCCmec region. DR, direct repeat sequence; IR, inverted repeat sequence.
